search
Back to results

Prevention Management Model for Early Childhood Caries (MAYA Project)

Primary Purpose

Dental Caries

Status
Completed
Phase
Phase 3
Locations
United States
Study Type
Interventional
Intervention
Chlorhexidine gluconate
Fluoride Varnish
Sponsored by
University of California, San Francisco
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Dental Caries focused on measuring Early childhood caries

Eligibility Criteria

18 Years - 33 Years (Adult)All SexesAccepts Healthy Volunteers

"Inclusion Criteria" Some evidence of geographic stability in South San Diego Bay Area Planning on remaining in area approximately 3 years after birth of child Must be able to provide consent in English or Spanish Must be registered patients at San Ysidro Health Center in the prenatal program Must be experiencing a normal pregnancy "Exclusion Criteria" Diabetes, anemia, placenta previa, seizure disorders, GDM, evidence of chromosomal disorders, Polyhydramnios, Thrombophlebitis, or RH-negative status Vaginal bleeding, premature uterine contractions, viral or bacterial infections, diabetes, pregnant with twins or multiple births expected Previous pregnancy complications where hospitalization was required

Sites / Locations

  • San Ysidro Health Center

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Counseling Only

CHX+Counseling (caregiver) + FV (child)

Arm Description

Oral Health Counseling Only

Oral Health Counseling plus Chlorhexidine for caregiver plus fluoride varnish every 6 months from 12mo to 30mo of age for child

Outcomes

Primary Outcome Measures

Caries Incidence and Caries Index
Caries Incidence (number of participants who developed caries during the study) and the number of decayed or filled tooth surfaces (dfs) index.

Secondary Outcome Measures

Full Information

First Posted
August 7, 2003
Last Updated
March 7, 2022
Sponsor
University of California, San Francisco
Collaborators
San Ysidro Health Center, University of California, San Diego, San Diego State University
search

1. Study Identification

Unique Protocol Identification Number
NCT00066950
Brief Title
Prevention Management Model for Early Childhood Caries (MAYA Project)
Official Title
Prevention Management Model for Early Childhood Caries
Study Type
Interventional

2. Study Status

Record Verification Date
March 2022
Overall Recruitment Status
Completed
Study Start Date
March 2003 (undefined)
Primary Completion Date
July 2005 (Actual)
Study Completion Date
August 2005 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
University of California, San Francisco
Collaborators
San Ysidro Health Center, University of California, San Diego, San Diego State University

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
The purpose of this study is to determine whether dental disease patterns and transmissable bacteria that are known to cause a severe form of dental decay in young children can be reduced or eliminated by treating mothers and their young infants early on with Chlorhexidine and fluoride varnish applications, respectively as part of a comprehensive Prevention Management Model.
Detailed Description
The primary aim is to evaluate two programs, a minimal intervention program and a moderate intensity program, for preventing Early Childhood Caries. A four-year randomized clinical trial will be conducted specifically to: 1) Assess demographic and behavioral factors as predictors of ECC and the relationship between three-year post-intervention behavioral changes from baseline measures with disease outcomes; 2) Compare the efficacy for the prevention of ECC in two groups - the minimal intervention group (Group 1) receiving counseling alone, with the moderate intensity group (Group 2) receiving a) counseling and a therapeutic four-month regimen of Chlorhexidine rinse for new mothers and b) fluoride varnish applications for their infants and toddlers starting at twelve months of age and continuing to age 30 months; 3) Assess baseline salivary microbiological markers as predictors of ECC in the infants of women in both groups and the relationship between three-year post-intervention salivary markers and changes from baseline measures with disease outcomes; 4) Assess the impact of a caries-preventive model in lowering the salivary mutans streptococci level in post-partum women, and subsequently, in inhibiting the growth of these bacteria in their young children, delaying the infectious process. The long term objectives are to build upon our understanding of caries risk factors, to assess the effectiveness of a prevention management model, to improve access to preventive oral health services and information for low-income pregnant women and their young children, and to reduce oral health disparities in a border population (U.S. - Mexico Border near San Diego Bay Area) at high risk for dental disease.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Dental Caries
Keywords
Early childhood caries

7. Study Design

Primary Purpose
Prevention
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantOutcomes Assessor
Allocation
Randomized
Enrollment
361 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Counseling Only
Arm Type
No Intervention
Arm Description
Oral Health Counseling Only
Arm Title
CHX+Counseling (caregiver) + FV (child)
Arm Type
Experimental
Arm Description
Oral Health Counseling plus Chlorhexidine for caregiver plus fluoride varnish every 6 months from 12mo to 30mo of age for child
Intervention Type
Drug
Intervention Name(s)
Chlorhexidine gluconate
Other Intervention Name(s)
Peridex® OMNII Oral Pharmaceuticals
Intervention Description
0.5oz chlorhexidine gluconate 0.12% solution mouth rinse twice daily for 14 days then no rinse for 14 days, repeated for 3 months
Intervention Type
Device
Intervention Name(s)
Fluoride Varnish
Other Intervention Name(s)
CavityShield® OMNII Oral Pharmaceuticals
Intervention Description
0.25ml FV every 6 months from age 12 to 30 months
Primary Outcome Measure Information:
Title
Caries Incidence and Caries Index
Description
Caries Incidence (number of participants who developed caries during the study) and the number of decayed or filled tooth surfaces (dfs) index.
Time Frame
4 year

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
33 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
"Inclusion Criteria" Some evidence of geographic stability in South San Diego Bay Area Planning on remaining in area approximately 3 years after birth of child Must be able to provide consent in English or Spanish Must be registered patients at San Ysidro Health Center in the prenatal program Must be experiencing a normal pregnancy "Exclusion Criteria" Diabetes, anemia, placenta previa, seizure disorders, GDM, evidence of chromosomal disorders, Polyhydramnios, Thrombophlebitis, or RH-negative status Vaginal bleeding, premature uterine contractions, viral or bacterial infections, diabetes, pregnant with twins or multiple births expected Previous pregnancy complications where hospitalization was required
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Francisco J Ramos-Gomez, DDS,MS, MPH
Organizational Affiliation
University of California, Los Angeles
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Stuart A Gansky, DrPH
Organizational Affiliation
University of California, San Francisco
Official's Role
Principal Investigator
Facility Information:
Facility Name
San Ysidro Health Center
City
San Ysidro
State/Province
California
ZIP/Postal Code
92173
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
18697848
Citation
Ramos-Gomez F, Chung LH, Gonzalez Beristain R, Santo W, Jue B, Weintraub J, Gansky S. Recruiting and retaining pregnant women from a community health center at the US-Mexico border for the Mothers and Youth Access clinical trial. Clin Trials. 2008;5(4):336-46. doi: 10.1177/1740774508093980.
Results Reference
result
PubMed Identifier
21999806
Citation
Ramos-Gomez FJ, Gansky SA, Featherstone JD, Jue B, Gonzalez-Beristain R, Santo W, Martinez E, Weintraub JA. Mother and youth access (MAYA) maternal chlorhexidine, counselling and paediatric fluoride varnish randomized clinical trial to prevent early childhood caries. Int J Paediatr Dent. 2012 May;22(3):169-79. doi: 10.1111/j.1365-263X.2011.01188.x. Epub 2011 Oct 17.
Results Reference
result
PubMed Identifier
24356441
Citation
Chaffee BW, Gansky SA, Weintraub JA, Featherstone JD, Ramos-Gomez FJ. Maternal oral bacterial levels predict early childhood caries development. J Dent Res. 2014 Mar;93(3):238-44. doi: 10.1177/0022034513517713. Epub 2013 Dec 19.
Results Reference
result

Learn more about this trial

Prevention Management Model for Early Childhood Caries (MAYA Project)

We'll reach out to this number within 24 hrs